Exploring alternatives for serialization and traceability of pharmaceutical products bound for China is crucial in ensuring compliance with stringent regulatory requirements and enhancing supply chain transparency. GS1 standards provide a robust framework for implementing unique identification, barcoding, and data sharing across the pharmaceutical supply chain. By adopting GS1’s global standards, manufacturers can effectively serialize their products, enabling accurate tracking from production to distribution. This not only helps in combating counterfeit drugs but also facilitates efficient recalls and enhances patient safety. As the Chinese market continues to evolve, leveraging GS1 for serialization and traceability offers pharmaceutical companies a reliable solution to navigate regulatory challenges while maintaining product integrity and consumer trust. In this session we explore:

• How to meet China’s stringent serialization and traceability regulations, ensuring legal compliance and market access?
• How to implementi GS1’s unique identification system allowing for accurate serialization of pharmaceutical products and enhancing tracking throughout the supply chain?
• How to counterfeit Prevention: Utilizing GS1 standards significantly reduces the risk of counterfeit drugs entering the market by enabling reliable product verification at various distribution points?
• How to ensure efficient Recalls: In the event of a product recall, GS1 facilitates rapid identification and retrieval of affected products, minimizing risks to patient safety and reducing financial losses?
• How to adopt GS1 for serialization and traceability improving visibility across the supply chain, fostering trust among stakeholders and ensuring the integrity of pharmaceutical products?